Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

Presentation TCT 2016

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Marco Moscarelli

October 31, 2016

Presentation TCT 2016

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

Presenter: Ted Feldman, Scott Lim, Steven F. Bolling

October 31, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard!

Presenter: James S. Gammie, James B. Hermiller Jr., Steven F. Bolling

October 30, 2016

Presentation TCT 2016

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective!

Presenter: James S. Gammie, James B. Hermiller Jr., Ted Feldman

October 30, 2016

Presentation TCT 2016

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Transcatheter MV Replacement Will Become Standard Of Care For Secondary MR!

Presenter: James S. Gammie, James B. Hermiller Jr., Stephan Windecker

October 30, 2016

News Daily News

More Proof That Specific Genetic Error Causes Thoracic Aortic Aneurysm, Dissection

Caitlin E. Cox

July 18, 2016

News Industry News

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

June 27, 2016

Presentation TVT 2016

Impact of MitraClip on Vavlular Dimensions in Secondary MR

Presenter: G. Burkhard Mackensen

June 17, 2016

Presentation TVT 2016

Anatomical Changes to the Mitral Apparatus in Secondary MR

Presenter: Philipp Blanke

June 17, 2016

News Conference News EuroPCR 2016

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

Shelley Wood

May 26, 2016

News Conference News ACC 2016

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Shelley Wood

April 12, 2016

News Conference News ACC 2016

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Shelley Wood

April 07, 2016

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Todd Neale

April 05, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Conference News CRT 2016

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Shelley Wood

February 25, 2016

News Conference News ISC 2016

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

Michael O'Riordan

February 23, 2016

News Conference News ISC 2016

REVASCAT: Thrombectomy’s Impact in Acute Stroke Extends to 1 Year

Todd Neale

February 18, 2016

News Conference News ISC 2016

PISTE Trial Adds to Mounting Evidence Supporting Endovascular Therapy in Acute Stroke

Todd Neale

February 17, 2016

Advertisement

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

How Good Can Surgical Outcomes Be in Secondary MR?

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard!

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective!

Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Transcatheter MV Replacement Will Become Standard Of Care For Secondary MR!

More Proof That Specific Genetic Error Causes Thoracic Aortic Aneurysm, Dissection

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

Impact of MitraClip on Vavlular Dimensions in Secondary MR

Anatomical Changes to the Mitral Apparatus in Secondary MR

‘Europe Isn’t Waiting’: MitraClip Moves Into New Niches, Big and Small

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

REVASCAT: Thrombectomy’s Impact in Acute Stroke Extends to 1 Year

PISTE Trial Adds to Mounting Evidence Supporting Endovascular Therapy in Acute Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content